CANVAS - CANagliflozin cardioVascular Assessment Study

Clinical trial NCT01032629 · COMPLETED

Trial details

NCT number: NCT01032629
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Cardiovascular Diseases Risk Factors

Start date: 2009-12-09
Primary completion: 2017-02-22
Enrollment: 4330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.